This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 Nov 8;173(10):1210; author reply 1210.

doi: 10.1503/cmaj.1050121.

Questioning the benefits of statins

PMID: 16275979
PMCID: PMC1277054
DOI: 10.1503/cmaj.1050121

Comment

Questioning the benefits of statins

Garey Mazowita. CMAJ. 2005.

. 2005 Nov 8;173(10):1210; author reply 1210.

doi: 10.1503/cmaj.1050121.

Author

PMID: 16275979
PMCID: PMC1277054
DOI: 10.1503/cmaj.1050121

No abstract available

PubMed Disclaimer

Comment on

Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update.
Genest J, Frohlich J, Fodor G, McPherson R; Working Group on Hypercholesterolemia and Other Dyslipidemias. Genest J, et al. CMAJ. 2003 Oct 28;169(9):921-4. CMAJ. 2003. PMID: 14581310 Free PMC article. No abstract available.
The 2003 Canadian recommendations for dyslipidemia management: revisions are needed.
Manuel DG, Tanuseputro P, Mustard CA, Schultz SE, Anderson GM, Ardal S, Alter DA, Laupacis A. Manuel DG, et al. CMAJ. 2005 Apr 12;172(8):1027-31. doi: 10.1503/cmaj.1040202. CMAJ. 2005. PMID: 15824409 Free PMC article. No abstract available.

Similar articles

Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
Gotto AM Jr, Farmer JA. Gotto AM Jr, et al. Nat Clin Pract Cardiovasc Med. 2006 Dec;3(12):664-72. doi: 10.1038/ncpcardio0711. Nat Clin Pract Cardiovasc Med. 2006. PMID: 17122799 Review.
Questioning the benefits of statins.
Vos E, Rose CP. Vos E, et al. CMAJ. 2005 Nov 8;173(10):1207; author reply 1210. doi: 10.1503/cmaj.1050120. CMAJ. 2005. PMID: 16275976 Free PMC article. No abstract available.
Lipids, statins and cardiovascular disease.
Cheifitz R. Cheifitz R. Climacteric. 2008 Aug;11(4):347-8; author reply 348-50. doi: 10.1080/13697130802242632. Climacteric. 2008. PMID: 18645702 No abstract available.
[Lipid-lowering cardiovascular prevention in type 2-diabetes. Statins are effective according to the FIELD study].
Båvenholm P, Attvall S, Nilsson PM. Båvenholm P, et al. Lakartidningen. 2006 Aug 30-Sep 5;103(35):2462-6. Lakartidningen. 2006. PMID: 17002161 Review. Swedish. No abstract available.
Lipid abnormalities and cardiovascular risk in the elderly.
Milionis HJ, Elisaf MS, Mikhailidis DP. Milionis HJ, et al. Curr Med Res Opin. 2008 Mar;24(3):653-7. doi: 10.1185/030079908X273363. Epub 2008 Jan 23. Curr Med Res Opin. 2008. PMID: 18218195

See all similar articles

References

1. Manuel DG, Tanuseputro P, Mustard CA, et al. The 2003 Canadian recommendations for dyslipidemia management: Revisions are needed [editorial]. CMAJ 2005;172(8):1027-31. - PMC - PubMed
1. Genest J, McPherson R, Frohlich J, et al. The analysis by Manuel and colleagues creates controversy with headlines, not data [editorial]. CMAJ 2005;172(8):1033-4. - PMC - PubMed
1. Manuel DG, Tanuseputro P, Mustard CA, et al. Rebuttal [editorial]. CMAJ 2005;172(8):1037.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information